These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3099556)

  • 1. Unique properties of auranofin as a potential anti-rheumatic drug.
    Barrett ML; Lewis GP
    Agents Actions; 1986 Oct; 19(1-2):109-15. PubMed ID: 3099556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis.
    Danis VA; Kulesz AJ; Nelson DS; Brooks PM
    Clin Exp Immunol; 1990 Mar; 79(3):335-40. PubMed ID: 2107989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of auranofin and sodium aurothiomalate on interleukin-1 production from human monocytes in vitro.
    Remvig L; Enk C; Bligaard N
    Scand J Rheumatol; 1988; 17(4):255-62. PubMed ID: 3142038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay.
    Haynes DR; Garrett IR; Whitehouse MW; Vernon-Roberts B
    J Rheumatol; 1988; 15(5):775-8. PubMed ID: 3139878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of piroxicam on mononuclear cells. Comparison with other antiarthritic drugs.
    Gordon D; Lewis GP
    Inflammation; 1984 Jun; 8 Suppl():S87-102. PubMed ID: 6332779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes.
    Scheinberg MA; Santos LM; Finkelstein AE
    J Rheumatol; 1982; 9(3):366-9. PubMed ID: 6288942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagenase production by human mononuclear cells in culture: inhibition by gold containing compounds and other antirheumatic agents.
    Ohta A; Louie JS; Uitto J
    Ann Rheum Dis; 1986 Dec; 45(12):996-1003. PubMed ID: 3028288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic modulation of TNF production by endotoxin stimulated macrophages: in vitro and in vivo effects of auranofin and other chrysotherapeutic compounds.
    Evans GF; Zuckerman SH
    Agents Actions; 1989 Mar; 26(3-4):329-34. PubMed ID: 2500010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent human leukocyte collagenase can be activated by gold thioglucose and gold sodium thiomalate, but not by auranofin.
    Sorsa T; Suomalainen K; Turto H; Lindy S
    Biosci Rep; 1987 Dec; 7(12):965-8. PubMed ID: 2840130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auranofin inhibits the induction of interleukin 1 beta and tumor necrosis factor alpha mRNA in macrophages.
    Bondeson J; Sundler R
    Biochem Pharmacol; 1995 Nov; 50(11):1753-9. PubMed ID: 8615853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gold compounds on function of phagocytic cells. Comparative inhibition of activated polymorphonuclear leukocytes and monocytes from rheumatoid arthritis and control subjects.
    Davis P; Johnston C
    Inflammation; 1986 Sep; 10(3):311-20. PubMed ID: 3017859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold salts inhibit osteoclastic bone resorption in vitro.
    Hall TJ; Jeker H; Nyugen H; Schaeublin M
    Inflamm Res; 1996 May; 45(5):230-3. PubMed ID: 8737745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells.
    Sfikakis PP; Souliotis VL; Panayiotidis PP
    Arthritis Rheum; 1993 Feb; 36(2):208-12. PubMed ID: 8431210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auranofin, gold thiomalate, and gold thioglucose inhibit protein kinase C.
    Mahoney CW; Hensey CE; Azzi A
    Biochem Pharmacol; 1989 Oct; 38(19):3383-6. PubMed ID: 2510733
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of auranofin on activation and interleukin-2 release from human peripheral blood mononuclear cells.
    Vint IA; Chain BM; Foreman JC
    Agents Actions; 1993 Nov; 40(3-4):209-14. PubMed ID: 8023745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modulation of interleukin 1 production by interferon gamma, and the inhibitory effects of gold compounds.
    Harth M; McCain GA; Cousin K
    Immunopharmacology; 1990; 20(2):125-34. PubMed ID: 2125034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of action of gold compounds].
    Vischer TL
    Wien Klin Wochenschr Suppl; 1984; 156():17-8. PubMed ID: 6442050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bimodal effect of gold on IL-1 production by blood monocytes.
    Danis VA; Kulesz A; Nelson DS; Brooks PM
    J Rheumatol; 1989 Aug; 16(8):1160-1. PubMed ID: 2511304
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of TPA-induced NF-kappaB nuclear translocation and production of NO and PGE2 by the anti-rheumatic gold compounds.
    Yamashita M; Ashino S; Oshima Y; Kawamura S; Ohuchi K; Takayanagi M
    J Pharm Pharmacol; 2003 Feb; 55(2):245-51. PubMed ID: 12631417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.